Atg16L2 inhibitors constitute a specialized class of chemical compounds that have gained prominence in the field of molecular biology and autophagy research. Atg16L2, or Autophagy-Related 16-Like 2, is a protein involved in the regulation of autophagy, a cellular process responsible for degrading and recycling cellular components to maintain cellular homeostasis and respond to various stress conditions. The term Atg16L2 inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of Atg16L2. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with Atg16L2.
Atg16L2 inhibitors typically function by interfering with the role of Atg16L2 in the initiation and formation of autophagic structures, such as autophagosomes, which are essential for the sequestration and degradation of cellular cargo. This interference can disrupt the normal process of autophagy, impacting various aspects of cellular quality control, stress response, and adaptation. Researchers employ Atg16L2 inhibitors to gain insights into the physiological roles and molecular interactions of Atg16L2 within cells, aiming to advance our understanding of the fundamental mechanisms involved in autophagy regulation. Through the study of Atg16L2 inhibitors, scientists seek to unravel the complexities of cellular self-cleaning processes, cellular responses to stress, and the broader field of cell biology, contributing to our knowledge of how cells maintain their health and adapt to changing environmental conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Spautin-1 promotes the degradation of Vps34 PI3 kinase complexes, potentially disrupting autophagy and indirectly affecting Atg16L2 expression or stability. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor; by inhibiting Vps34, it may dampen autophagy initiation, potentially altering Atg16L2 expression as part of the cellular response. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
3-Methyladenine (3-MA) inhibits Class III PI3K, which is crucial for autophagy initiation, possibly leading to reduced Atg16L2 expression associated with autophagy machinery. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine disrupts autophagosome-lysosome fusion; while not a direct inhibitor of Atg16L2 expression, it influences autophagy pathways where Atg16L2 is integral. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $56.00 | 1 | |
Hydroxychloroquine, similar to Chloroquine, affects autophagosome function and may indirectly modify the expression or stability of autophagy-related proteins like Atg16L2. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits the vacuolar H+ ATPase and impairs autophagosome-lysosome fusion which could influence Atg16L2 turnover. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
SAR405 is a specific inhibitor of Vps34, which could disrupt the formation of autophagosomes, potentially reducing the requirement for Atg16L2 activity. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $240.00 | 7 | |
Torin 1 targets mTOR, a central regulator of autophagy; inhibition of mTOR can induce autophagy, potentially altering Atg16L2 expression levels in response. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Although previously mentioned for another protein, LY294002's role in PI3K inhibition could similarly affect Atg16L2 expression through autophagy modulation. | ||||||
SBI-0206965 | 1884220-36-3 | sc-507431 | 10 mg | $122.00 | ||
SBI-0206965 is an inhibitor of the autophagy kinase ULK1; inhibition of ULK1 activity could impact Atg16L2's role in autophagosome formation. | ||||||